- Report
- September 2025
- 286 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 483 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 265 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 194 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 602 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 194 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 193 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 194 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 193 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 192 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 179 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 303 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 601 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- June 2025
- 185 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- September 2025
- 364 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 283 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 285 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 368 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 364 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 93 Pages
Global
From €5142EUR$5,850USD£4,448GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more